Increasing cervical cancer screening at a non-government medical center in Lilongwe, Malawi.

Africa < location Human papillomavirus < viral disease human immunodeficiency virus < viral disease screening < other women < other

Journal

International journal of STD & AIDS
ISSN: 1758-1052
Titre abrégé: Int J STD AIDS
Pays: England
ID NLM: 9007917

Informations de publication

Date de publication:
09 2021
Historique:
pubmed: 30 4 2021
medline: 21 9 2021
entrez: 29 4 2021
Statut: ppublish

Résumé

Malawi has the highest incidence of and mortality rate due to cervical cancer in the world. This is largely because of inadequate screening and high rates of human immunodeficiency virus (HIV) infection, which greatly increases cervical cancer risk. We describe the implementation of a quality improvement program to increase use of cervical cancer screening at a non-government medical center in Lilongwe, Malawi. The intervention, developed and launched from March to August 2017, aimed to promote education among patients and clinicians about the importance of cervical cancer screening and improve accessibility of screening information within medical records. Visual inspection with acetic acid (VIA) was used to screen for cervical cancer. Women with a positive VIA were offered treatment using thermocoagulation. The number of VIA screenings conducted in 2016 (pre-intervention), 2017 (intervention), and 2018 (post-intervention) was 125, 234 and 456, respectively. Of the 815 women screened during this period, 36 (4.4%) had a VIA-positive result and 12 (1.5%) had suspect cancer. Of the VIA-positive women, 13 (36.1%) received same-day treatment with thermocoagulation. An interrupted time series regression revealed that there was a sustained increase in monthly screenings between the pre- and post-intervention period (

Identifiants

pubmed: 33910402
doi: 10.1177/09564624211007260
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

933-939

Auteurs

Preeti Kakani (P)

12222David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA.

Noah Kojima (N)

Department of Internal Medicine, 12222University of California at Los Angeles, Los Angeles, CA, USA.

Ben A Banda (BA)

Partners in Hope, Lilongwe, Malawi.

Samuel Lewis (S)

12222David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA, USA.

Rajat Suri (R)

Department of Internal Medicine, 12222University of California at Los Angeles, Los Angeles, CA, USA.

Florence Chibwana (F)

Partners in Hope, Lilongwe, Malawi.

Mackenzie Chivwara (M)

Partners in Hope, Lilongwe, Malawi.

Lauren Sullivan (L)

Department of Internal Medicine, 12222University of California at Los Angeles, Los Angeles, CA, USA.

Mayamiko Chimombo (M)

Partners in Hope, Lilongwe, Malawi.

Hitler Sigauke (H)

Partners in Hope, Lilongwe, Malawi.

Chris Tymchuk (C)

Department of Internal Medicine, 12222University of California at Los Angeles, Los Angeles, CA, USA.

Daniel Kahn (D)

Department of Internal Medicine, 12222University of California at Los Angeles, Los Angeles, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH